alprazolam XR extended-release tablets — Class II drug recall D-0844-2022
Terminated recall by Viatris Inc, reported 2022-05-11, distributed nationwide. Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
| Recall number | D-0844-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Viatris Inc, Canonsburg, PA, United States |
| Recall initiated | 2022-04-28 |
| Classified | 2022-05-03 |
| Reported by FDA | 2022-05-11 |
| Terminated | 2023-06-21 |
| Distributed | Nationwide (US) |
| Quantity | 6,789 bottles |
| Reason classes | specification failure |
| NDC | 59762-0057, 59762-0057-01, 59762-0059, 59762-0059-01, 59762-0066, 59762-0066-01, 59762-0068, 59762-0068-01 |
| Lot numbers | EH8348 |
| Expiration dates | 2023-08-20 |
Product
alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.
Reason for recall
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0844-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.